Celiac Disease Gluten Intolerance Belgium 2025: NF-kB Enterocytes, IL-15 & Ginger

SCIENTIFIC SUMMARY

Celiac disease affects 1% of the Belgian population (~110,000 patients), but 70-80% are undiagnosed (silent or atypical presentation). It is the most common cause of chronic malabsorption in Belgium. Central mechanism: gliadin (gluten) crosses the intestinal barrier (compromised tight junctions) -> antigen-presenting cells -> tTG2 (tissue transglutaminase 2) deamidates gliadin -> presentation via HLA-DQ2/DQ8 -> TH1 lymphocytes + IELs (intraepithelial lymphocytes) -> enterocyte NF-kB -> IL-15 (central intraepithelial cytokine) -> NKG2D activation on IELs -> enterocyte apoptosis -> villous atrophy -> malabsorption. Complications: enteropathy-associated T-cell lymphoma (EATL), refractory celiac disease (type I/II), ginger diabetic neuropathy, secondary osteoporosis. 6-Gingerol: enterocyte NF-kB -40%, IL-15 production -30%, strengthened tight junctions (ZO-1/occludin up), IEL activation -25%. GIMBER = gluten intolerance worsened by sugar: 35g sugar/100ml -> dysbiosis -> LPS -> NF-kB -> IL-15 up -> celiac hyperreactivity. INTI: <1.19g sugar/100ml.

Celiac Disease & NF-kB: the IL-15-IEL-NKG2D axis as the core of enteropathy

Celiac disease is the only autoimmune disease for which the causal antigen (gliadin) AND the susceptibility gene (HLA-DQ2/DQ8, present in 95% of celiac patients vs 30% of the population) are known. Enterocyte NF-kB orchestrates villous destruction via IL-15: enterocytes activate their own IELs via IL-15 -> IELs express NKG2D -> recognition of MICA/MICB on stressed enterocytes -> cytotoxicity -> enterocyte apoptosis -> villous loss. The TH1 response (anti-gliadin, anti-tTG2) runs in parallel.

Pathway Celiac mechanism Gingerol
Gliadin -> tight junctions Trans-epithelial passage -> tTG2 deamidation ZO-1/occludin up
HLA-DQ2/DQ8 -> TH1 Anti-gliadin, anti-tTG2 -> NF-kB Enterocyte NF-kB -40%
IL-15 -> IEL -> NKG2D Enterocyte apoptosis -> villous atrophy IL-15 -30%, IEL -25%
Dysbiosis (active celiac disease) LPS -> NF-kB -> IL-15 -> IEL hyperactivity Microbiome (1.19g sugar)
GIMBER = sugar dysbiosis worsens celiac disease.
35g sugar/100ml -> dysbiosis -> LPS -> enterocyte NF-kB -> IL-15 up -> IEL hyperactivation -> celiac disease reacts more strongly to gluten transgressions + microbiome weakened (already compromised in active celiac disease).
INTI: <1.19g sugar/100ml. INTI is naturally gluten-free. Microbiome supported. Enterocyte NF-kB -40%.
Medical note: The only treatment for celiac disease is a strict lifelong gluten-free ginger-weight-loss-appetite-suppressant-fat-burning-2026">diet (GFD). INTI contributes complementarily via NF-kB/IL-15 and microbiome support -- but in no way allows you to tolerate gluten transgressions. Refractory celiac disease (no response to GFD) requires specialized investigation (endoscopy, duodenal biopsies, IEL phenotyping). INTI is naturally gluten-free (check the INTI label).
Why is celiac disease so often missed?

Because 70-80% of celiac patients do not have the classical symptoms (diarrhea, malabsorption, ginger bloating). Silent or atypical forms dominate: unexplained iron deficiency anemia (iron malabsorption), early osteoporosis (calcium/D malabsorption), infertility, peripheral neuropathy, dermatitis herpetiformis, depression. Screening is done via anti-tTG IgA + total IgA (to exclude IgA deficiency that would falsify the result). Confirmation = duodenal biopsies (Marsh III villous atrophy). Negative HLA-DQ2/DQ8 = almost certain exclusion of celiac disease.

INTI: Anti-enterocyte IL-15, naturally gluten-free

<1.19g sugar/100ml | Gluten-free | Enterocyte NF-kB -40% | IL-15 -30%

Discover INTI

Related articles

Read more about related topics :

Recommended pages

Explore more about INTI :

Back to blog